Mana Ventures logo

Mana Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

12

Common Fundraising Type

Seed

OneRail logo
OneRail

Last-mile delivery • Delivery optimization

Piva Capital logo
Mana Ventures logo
Las Olas Venture Capital logo
Gaingels logo

OneRail provides last-mile delivery solutions by optimizing delivery operations through a platform connected to a network of drivers and logistics companies.

Series C
$42M
12/03/2024
Article
Raven Space Systems logo
Raven Space Systems

3D printing • Thermoset composites

What If Ventures logo
Mana Ventures logo
Cape Fear Ventures logo
Backswing Ventures logo

Raven Space Systems develops 3D printing technology for producing thermoset composite components for aerospace applications.

Seed
$2M
11/20/2024
Article
ANELLO Photonics logo
ANELLO Photonics

Silicon Photonics • Optical Gyroscope

ANELLO Photonics develops Silicon Photonic Optical Gyroscope technology to enhance navigation and positioning in GPS-denied environments for industrial and defense applications.

Series B
Undisclosed
11/19/2024
Article
XDLINX logo
XDLINX

Satellite platform manufacturing • Spacecraft platforms

Lucky Investments logo
Mana Ventures logo
E2MC logo

XDLINX Space Labs is an India-based space-tech company that specializes in manufacturing satellite platforms and payload technology for commercial and defense ISR space missions.

Seed
$7M
10/20/2024
Article
Gladia logo
Gladia

AI transcription • Audio intelligence

XTX Ventures logo
XAnge logo
Soma Capital logo
Roosh Ventures logo

Gladia specializes in AI transcription and audio intelligence, offering a multilingual real-time speech-to-text API that supports over 100 languages.

Series A
$16M
10/15/2024
Article
Arda Therapeutics logo
Arda Therapeutics

Targeted cell depletion • Chronic diseases

Andreessen Horowitz logo
Two Sigma Ventures logo
RV Invest logo
Eli Lilly and Company logo

Arda Therapeutics develops targeted cell depletion therapies for chronic diseases.

Series A
$43M
10/09/2024
Article
VerImmune logo
VerImmune

Biotechnology • Cancer immunotherapy

Proxima Ventures logo
Beiley Biofund logo
Mana Ventures logo
Gaingels logo

VerImmune Inc. is a biotechnology company developing a novel cancer immunotherapy that redirects pre-existing immune memory towards tumors using their ViP™ platform technology.

Series A
$4.5M
09/23/2024
Article
Neurophos logo
Neurophos

AI computation • Metasurface

MetaVC logo
Mana Ventures logo
Gates Frontier logo

Neurophos is developing an innovative AI inference acceleration technology by combining optical metasurfaces with silicon photonics to create a more efficient and dense tensor core processor for faster AI computations.

Seed
$7.2M
12/14/2023
Article
Datalogz logo
Datalogz

Business Intelligence • Data Management

Trajectory Ventures logo
Squadra Ventures logo
Mana Ventures logo
Graphene Ventures logo

Datalogz is a startup that provides a platform to streamline business intelligence environments by automating the detection and fixing of issues like data duplication, misreporting, and inefficient queries within data-mature organizations.

Equity
$5M
12/14/2023
Article
Pepper Bio logo
Pepper Bio

Drug Discovery • Transomics

VSC Ventures logo
Tensility Ventures logo
Silverton Partners logo
NFX logo

Pepper Bio is a transomics-driven drug discovery startup working to enhance the drug development process by integrating multi-layered biological data to address oncology challenges and reduce failure rates in drug discovery.

Seed
$6.5M
11/30/2023
Article
Mundi logo
Mundi

Fintech • Cross-border Trade

Upper90 logo
Union Square Ventures logo
Mana Ventures logo
Haymaker Ventures logo

Mundi is a fintech platform that simplifies cross-border trade in Latin America by offering services such as International Payments and Collections, FX Spot Trading and Hedging, Cargo Insurance, and a suite of free tools and insights.

Series A
$15M
09/27/2023
Article
VerImmune logo
VerImmune

Biotechnology • Cancer immunotherapy

Proxima VC logo
Mana Ventures logo
Gaingels logo

VerImmune Inc. is a biotechnology company developing a novel cancer immunotherapy that redirects pre-existing immune memory towards tumors using their ViP™ platform technology.

Seed
$3.1M
09/20/2023
Article